Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia

Cellectis S.A. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
acute myeloid leukaemia, newly diagnosed aml, eln adverse genetic risk group, chimeric antigen receptor t-cell (car-t) therapy, allogeneic, transcription activator-like effector nuclease (talen), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 908599
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.